http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2371178-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4860de128cf52cce9a92bbc456d74184 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate | 2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5428a7a1bdd9ff57e24265e703558773 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dd9fc4ed9cdb68e3fedd73b85876fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b4f0ebc41bcbbdb68da3f87f0089518 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a3c05da17c3fae0708c9a33a53a7b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c5d4cb5097b7f8cc7fddb85236c2ebe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a0e8f514ecac461789b6783d9555491 |
| publicationDate | 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2371178-C1 |
| titleOfInvention | Method of pre-operation preparation of pheochromocytoma case |
| abstract | FIELD: medicine. n SUBSTANCE: invention concerns medicine, particularly endocrinology and anesthesiology, and can be applied in pre-operation preparation of pheochromocytoma cases. It involves peroral administration of doxazozin drug in 14-21 day before operation. Initial daily drug dosage is 4 mg, by 2 mg twice per day, with further dosage increase by 2-4 mg till arterial pressure is normalised. Maximum dosage is 16 mg per day. After arterial pressure stabilisation daily doxazozin administration continues in determined therapeutic dosage. Last doxazozin take is performed in 90 minutes before narcosis in dosage of 8-12 mg. n EFFECT: prevented hypertensive crisis caused by hypercatecholaminemia during the whole operation due to timely maintenance of selective al-adrenoreceptor blockade. n 1 tbl, 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2616896-C1 |
| priorityDate | 2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.